Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

BUY
$0.46 - $1.29 $36 - $101
79 Added 0.36%
22,226 $10,000
Q2 2022

Jul 29, 2022

SELL
$0.79 - $5.98 $5,323 - $40,299
-6,739 Reduced 23.33%
22,147 $19,000
Q1 2022

Apr 29, 2022

SELL
$4.25 - $10.4 $5,142 - $12,584
-1,210 Reduced 4.02%
28,886 $159,000
Q4 2021

Feb 07, 2022

SELL
$9.68 - $17.74 $149,023 - $273,107
-15,395 Reduced 33.84%
30,096 $291,000
Q3 2021

Nov 01, 2021

BUY
$17.6 - $25.91 $349,976 - $515,220
19,885 Added 77.66%
45,491 $813,000
Q2 2021

Aug 12, 2021

SELL
$22.26 - $28.43 $112,613 - $143,827
-5,059 Reduced 16.5%
25,606 $625,000
Q1 2021

May 13, 2021

SELL
$8.02 - $32.01 $13,634 - $54,417
-1,700 Reduced 5.25%
30,665 $813,000
Q4 2020

Feb 04, 2021

BUY
$4.23 - $8.73 $76,254 - $157,375
18,027 Added 125.73%
32,365 $246,000
Q3 2020

Nov 09, 2020

SELL
$4.65 - $6.25 $130,669 - $175,631
-28,101 Reduced 66.22%
14,338 $72,000
Q2 2020

Jul 20, 2020

BUY
$4.01 - $6.88 $32,112 - $55,095
8,008 Added 23.26%
42,439 $254,000
Q1 2020

Apr 30, 2020

BUY
$3.74 - $9.84 $65,158 - $171,432
17,422 Added 102.43%
34,431 $153,000
Q4 2019

Jan 28, 2020

SELL
$7.23 - $14.12 $19,788 - $38,646
-2,737 Reduced 13.86%
17,009 $162,000
Q3 2019

Nov 04, 2019

BUY
$7.85 - $15.75 $155,006 - $310,999
19,746 New
19,746 $155,000
Q2 2019

Jul 29, 2019

SELL
$13.5 - $19.94 $87,237 - $128,852
-6,462 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$13.27 - $18.51 $85,750 - $119,611
6,462 New
6,462 $117,000

Others Institutions Holding RUBY

About Rubius Therapeutics, Inc.


  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.